bpc-157 neuroprotection Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review BPC-157 as an Investigational Peptide
Description
MT-II is not approved by any regulatory body
A role for TGF-beta1-induced cellular responses during wound healing of the non-scarring early human fetus
Not all patients experience significant relief, and research has shown mixed results regarding their overall effectiveness
Overall, 7075% of facial paralysis cases are Bells Palsy, and 2530% are secondary facial paralysis
